• Advonex

Advonex International Announces Attendance at Advanced Bioeconomy Leadership Conference on NextGen T


FOR IMMEDIATE RELEASE – Kingston, ON – Advonex International, today announced it will attend a 3-day ABLC Next Conference on November 2-4 at the Hotel Nikko in San Francisco, California. The conference will bring together emerging industry players and established brands to showcase their latest developments in advanced technology and sustainability. This is part of a broader effort by the company to showcase its platform technology and establish strategic partnerships in the bio-based chemicals sector.

Speakers will cover a lineup of technologies for advanced nutrition, advanced fuels, advanced chemicals, advanced materials, advanced crops, advanced AgTech, advanced genetics and microbe development.

“This is one of the premier North American conferences on the bioeconomy,” said Chad Joshi, CEO. “It is focused on developing synergies between technology developers and established chemicals players, and agribusiness which is in-line with Advonex’s business strategy.”

About Advonex International Advonex International, an innovator in the bio-chemicals industry, produces hydrocarbons from biological feedstock through its patented process innovations. These renewable hydrocarbons enable high-performance lubricants, organic, renewable cosmetics and lotions by replacing petroleum-based ingredients with better performing renewable components. Our Science. Your Business. Better World.

For further information about our new products and market opportunities, please contact:

Contact Advonex International Corporation Chad Joshi, CEO 945 Princess Street Kingston, ON K7L 0E9 Canada: 1 613-767-9285 USA: 1 978-259-0100 info@advonexintl.com www.advonexintl.com



0 views
CONTACT US

info@advonexintl.com

Canada: 613.767.9285

USA: 978.259.0100

3011 Highway 29, Unit 5

Brockville, ON K6V 5T4

Canada

SOCIAL
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon

© 2018 by Advonex International Corporation.